Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Angstrom Bio
AddedFeb 16, 2024
UpdatedJun 18, 2026
Angstrom Bio

Angstrom Bio

Seed

Angstrom Bio, a biotech firm, innovatively applies nucleotide chemistry and machine learning.

HQ
Austin, TX, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Angstrom Bio, founded with a mission to revolutionize diagnostics, leverages advanced nucleotide chemistry and machine learning to enhance human health. The company focuses on maximizing the reach of amplicon sequencing diagnostics, aiming to save, prolong, and improve lives. Their core product, a massively parallel diagnostic platform, offers population-scale molecular diagnostics with unprecedented throughput, unrivaled sensitivity, and cost efficiency. Angstrom Bio's technology is particularly critical in the fight against COVID-19 and other health challenges.

Notable affiliated individuals and investors include experts in biotechnology and machine learning, although specific names are not provided. Key achievements include the development of a scalable diagnostic platform that significantly enhances the sensitivity and throughput of molecular diagnostics. Angstrom Bio's impact is marked by its innovative approach to diagnostics, which has the potential to transform healthcare by making advanced diagnostic tools more accessible and effective on a global scale.

Angstrom Bio - Similar Companies

Amplified Sciences logo

Amplified Sciences

Nanopath logo

Nanopath

nanopathdx.com

Prompt Diagnostics logo

Prompt Diagnostics

prompt-dx.com

INanoBio logo

INanoBio

inanobio.com

Abterra Biosciences logo

Abterra Biosciences

abterrabio.com

Aperture Bio logo

Aperture Bio

aperture.bio

Complete Omics logo

Complete Omics

completeomics.com

Nuclein logo

Nuclein

nuclein.com

Aegirbio logo

Aegirbio

aegirbio.com

PreDxion Bio logo

PreDxion Bio

predxionbio.com

Quadrant Biosciences logo

Quadrant Biosciences

Angiex logo

Angiex

angiex.com

Signatur Biosciences logo

Signatur Biosciences

signatur.bio

Delve Bio logo

Delve Bio

delve.bio

Summit Biolabs logo

Summit Biolabs

summitbiolabs.com

Angstrom Bio - Quick Facts

Who are Angstrom Bio's competitors?

Companies similar to Angstrom Bio include Amplified Sciences, Nanopath, Prompt Diagnostics and INanoBio.

When was Angstrom Bio founded?

Angstrom Bio was founded in 2019.

Where is Angstrom Bio's headquarters located?

Angstrom Bio's headquarters is located in Austin, TX, US.

When was Angstrom Bio's last funding round?

Angstrom Bio's most recent funding round was for $3M (USD) in June 2021.

How much has Angstrom Bio raised to-date?

As of Jun 16, 2021, Angstrom Bio has raised a total of $3M (USD).

How many employees does Angstrom Bio have?

Angstrom Bio has 7 employees as of Feb 5, 2024.

Angstrom Bio - Classification

Ownership
  • Venture Capital
Technology
  • Machine Learning
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Diagnostics
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software